tiprankstipranks

Anand Mehra Insider Profile

4 Followers
Anand Mehra, Director at Spark Therapeutics, holds 16.21K shares in Aclaris Therapeutics (Ticker: ACRS), holds 0.00 shares in Spark Therapeutics (Ticker: ONCE), holds 28.00K shares in Marinus (Ticker: MRNS).
tipranks
Anand Mehra

Anand Mehra
Spark Therapeutics (ONCE)
Director

Ranked #8,993 out of 78,624 Corporate Insiders

Profitable Transactions

72%
13 out of 18 Profitable Transactions

Average Return

+10.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$7M
92.94%
6.24%
0.82%
A breakdown of Anand Mehra's holdings

Insider Roles

Aerie Pharma
(AERI)
Director
Marinus
(MRNS)
Director, Ten Percent Owner
Aclaris Therapeutics
(ACRS)
Director
Roles that Anand Mehra holds in companies

Most Profitable Insider Trade

Stock:
Spark Therapeutics
(ONCE)
Rating:Informative Buy
Date:Jan 08, 2019 - Jan 08, 2020
Return:+155.00%
The most profitable trade made by Anand Mehra

Anand Mehra's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ONCE
Spark Therapeutics
Dec 17, 2019
Uninformative Sell
59.71M
$0.00
Aclaris Therapeutics
Jun 08, 2020
Director
Uninformative Buy
$53.81K
Aerie Pharma
Apr 16, 2015
Director
Informative Sell
14.29M
$6.10M
Marinus
Oct 24, 2016
Director, Ten Percent Owner
Informative Sell
1.04M
$409.89K
List of latest transactions for each holding click on a transaction to see Anand Mehra's performance on stock

Anand Mehra insider profile FAQ

What is the percentage of profitable transactions made by Anand Mehra?
The percentage of profitable transactions made by Anand Mehra is 72%.
    What is the average return per transaction made by Anand Mehra?
    The average return per transaction made by Anand Mehra is 10.10%.
      What stocks does Anand Mehra hold?
      Anand Mehra holds: ONCE, ACRS, AERI, MRNS stocks.
        What was Anand Mehra’s latest transaction?
        Anand Mehra latest transaction was an Uninformative Buy of ―.
          What was Anand Mehra's most profitable transaction?
          Anand Mehra’s most profitable transaction was an Informative Buy of ONCE stock on January 8, 2019. The return on the trade was 155.00%.
            What is Anand Mehra's role in Spark Therapeutics?
            Anand Mehra's role in Spark Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.